David Saperstein
- Neurology top 0.5%
- Peripheral Neuropathies and Disorders 20
- Amyotrophic Lateral Sclerosis Research 11
- Botulinum Toxin and Related Neurological Disorders 7
- Myasthenia Gravis and Thymoma 5
-
- Hereditary Neurological Disorders 14
- Rheumatology top 2%
- Genetics top 5%
-
- Peripheral Nerve Disorders 9
-
- Inflammatory Myopathies and Dermatomyositis 9
-
- Pain Mechanisms and Treatments 8
- Co-authors
- Richard J. BarohnJonathan KatzAnthony A. AmatoSharon NationsGil I. WolfeGary GronsethTodd LevineJ.S. Katz
- Partner nations
- United StatesCanadaItaly
In The Last Decade
David Saperstein
54 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 97
- Neurology 1.4k
- Cellular and Molecular Neuroscience 824
- Rheumatology 360
- Genetics 205
- Radiology, Nuclear Medicine and Imaging 344
Countries citing papers authored by David Saperstein
This map shows the geographic impact of David Saperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Saperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Saperstein more than expected).
Fields of papers citing papers by David Saperstein
This network shows the impact of papers produced by David Saperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Saperstein. The network helps show where David Saperstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Saperstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2017 | 4 | |
| 7 | 2016 | 7 | |
| 8 | 2014 | 37 | |
| 9 | 2013 | 1 | |
| 10 | 2010 | 29 | |
| 11 | 2008 | 6 | |
| 12 | 2006 | 80 | |
| 13 | 2004 | 36 | |
| 14 | 2003 | 2 | |
| 15 | 2003 | 10 | |
| 16 | 2002 | 32 | |
| 17 | 2001 | 15 | |
| 18 | 2001 | 26 | |
| 19 | 2000 | 5 | |
| 20 | 1999 | 190 |
About David Saperstein
David Saperstein is a scholar working on Neurology, Cellular and Molecular Neuroscience, Genetics, Biochemistry and Radiology, Nuclear Medicine and Imaging, having authored 60 papers that have together received 2.2k indexed citations. Recurring topics across this work include Peripheral Neuropathies and Disorders (20 papers), Hereditary Neurological Disorders (14 papers), Amyotrophic Lateral Sclerosis Research (11 papers), Peripheral Nerve Disorders (9 papers), Inflammatory Myopathies and Dermatomyositis (9 papers), Pain Mechanisms and Treatments (8 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Myasthenia Gravis and Thymoma (5 papers). The work is most often cited by research in Neurology (1.4k citations), Cellular and Molecular Neuroscience (824 citations), Rheumatology (360 citations), Genetics (205 citations) and Radiology, Nuclear Medicine and Imaging (344 citations). David Saperstein has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Richard J. Barohn, Jonathan Katz, Anthony A. Amato, Richard J. Barohn, Sharon Nations, Gil I. Wolfe, Gary Gronseth, Todd Levine, J.S. Katz and Wilson W. Bryan. Their work appears in journals such as Neurology, Muscle & Nerve, Seminars in Neurology, Current Treatment Options in Neurology and Neurologic Clinics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.